XML 80 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Operating Activities      
Net income $ 140,249 $ 105,528 $ 135,393
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 190,778 192,005 158,026
Impairment of land parcel 0 2,050 0
Loss on early extinguishment of debt 1,992 2,225 6,485
Loss (gain) on sale of real estate 121 (1,564) 0
Impairment of real estate 0 11,400 994
Gain on sale of land parcels (4,824) (1,864) (46)
Amortization of loan fees and costs 9,936 9,832 9,300
Amortization of debt premiums/discounts 529 511 3,819
Amortization of acquired above and below market leases (3,316) (3,200) (9,332)
Deferred rent (27,935) (28,456) (26,797)
Stock compensation expense 15,552 14,160 11,755
Investment gains (7,050) (15,018) (4,846)
Investment losses 1,480 2,637 1,795
Changes in operating assets and liabilities:      
Restricted cash 899 (261) (465)
Tenant receivables (1,519) (981) (2,359)
Deferred leasing costs (54,825) (45,099) (56,226)
Other assets (6,298) (4,069) (22,359)
Accounts payable, accrued expenses, and tenant security deposits 56,958 65,697 41,823
Net cash provided by operating activities 312,727 305,533 246,960
Investing Activities      
Proceeds from sale of properties 153,968 36,179 20,078
Additions to properties (593,389) (549,030) (430,038)
Purchase of properties (122,069) (42,171) (305,030)
Change in restricted cash related to construction projects 7,655 (9,377) (2,183)
Distribution from unconsolidated real estate entity 0 22,250 0
Contributions to unconsolidated real estate entity (17,987) (6,700) (5,256)
Additions to investments (36,078) (36,294) (27,999)
Proceeds from investments 16,525 27,043 16,849
Net cash used in investing activities (591,375) (558,100) (733,579)
Financing Activities      
Borrowings from secured notes payable 28,489 17,810 0
Repayments of borrowings from secured notes payable (36,219) (26,367) (66,849)
Proceeds from issuance of unsecured senior notes payable 498,561 544,650 0
Principal borrowings from unsecured senior line of credit and unsecured senior bank term loans 729,000 847,147 1,406,000
Repayments of borrowings from unsecured senior line of credit (1,091,000) (651,147) (1,784,000)
Principal borrowings from unsecured senior bank term loans 0 0 1,350,000
Repayment of unsecured senior bank term loan (250,000) (250,000) (500,000)
Repurchase of unsecured senior convertible notes (384) (84,801) (221,439)
Redemption of Series C Cumulative Redeemable Preferred Stock 0 (129,638) 0
Proceeds from issuance of Series E Cumulative Redeemable Preferred Stock 0 124,868 0
Change in restricted cash related to financings 2,546 (7,428) 7,311
Deferred financing costs paid (19,928) (13,225) (27,316)
Proceeds from common stock offering 534,469 97,890 451,539
Proceeds from exercise of stock options 0 155 2,117
Dividends paid on common stock (169,076) (126,498) (106,889)
Dividends paid on preferred stock (25,885) (27,819) (28,357)
Contributions by redeemable noncontrolling interests 0 0 9
Distributions to redeemable noncontrolling interests (1,191) (1,249) (1,263)
Redemption of redeemable noncontrolling interests 0 (450) 0
Contributions by noncontrolling interests 0 1,875 1,000
Distributions to noncontrolling interests (1,812) (913) (2,707)
Net cash provided by financing activities 197,570 314,860 479,156
Effect of foreign exchange rate changes on cash and cash equivalents (2,197) 139 (5,230)
Net (decrease) increase in cash and cash equivalents (83,275) 62,432 (12,693)
Cash and cash equivalents at beginning of period 140,971 78,539 91,232
Cash and cash equivalents at end of period 57,696 140,971 78,539
Supplemental Disclosure of Cash Flow Information      
Cash paid during the period for interest, net of interest capitalized 59,857 52,561 52,324
Non-Cash Investing Activities      
Note receivable from sale of real estate 38,820 6,125 0
Write-off of fully amortized improvements 0 (17,730) 0
Change in accrued capital expenditures $ (21,310) $ 46,087 $ 3,492